Cost-effectiveness of treatments for pleural infection at 12 months
Incremental costs EUR (95% CI) | Incremental life-years (95% CI) | Incremental cost-effectiveness ratio | Probability of intervention being cost-effective# | |
t-PA–DNase | 0.86 | |||
t-PA | 3357 (−335–8114) | 0.019 (−0.025–0.062) | EUR 178 166 | 0.12 |
Placebo | 2878 (−4280–10 874) | −0.019 (−0.061–0.020) | t-PA both more effective and less costly | 0.03 |
DNase | 4373 (−6700–15 940) | −0.045 (−0.116–0.016) | t-PA both more effective and less costly | 0.001 |
t-PA: tissue plasminogen activator. #: assuming a cost-effectiveness threshold of GBP 30 000 (EUR 34 220) per life-year gained.